Excellent - I now have a complete, authoritative picture from Harrison's. Here is the full answer:
Causes of QT Prolongation
The QT interval reflects ventricular depolarization + repolarization. Prolongation occurs when repolarization is delayed - usually by impaired K+ outward current (IKr, IKs) or enhanced Na+/Ca2+ inward current. A corrected QT (QTc) >470 ms in men or >480 ms in women is considered prolonged.
The main risk is torsades de pointes (TdP) - a polymorphic VT that can degenerate into ventricular fibrillation.
1. Congenital Long QT Syndromes
These are ion channel mutations, accounting for ~15 subtypes. LQT1-3 together explain 80-90% of cases:
| Type | Gene | Channel affected | Trigger | ECG |
|---|
| LQT1 | KCNQ1 | ↓ IKs (slow K+) | Exercise, swimming | Broad T-wave |
| LQT2 | KCNH2 | ↓ IKr (rapid K+) | Sudden auditory stimuli, emotion | Notched/low T-wave |
| LQT3 | SCN5A | ↑ INa (Na+ gain-of-function) | Sleep | Long J-to-T delay |
- Romano-Ward syndrome - autosomal dominant, most common
- Jervell and Lange-Nielsen syndrome - autosomal recessive + sensorineural deafness
2. Electrolyte Abnormalities
- Hypokalemia - most important (reduces repolarizing K+ current; common precipitant in patients with underlying LQTS)
- Hypomagnesemia
- Hypocalcemia (hypercalcemia actually shortens QT)
3. Drugs (Acquired LQTS) - Largest Category
Most drugs act by blocking the hERG channel (IKr).
Antiarrhythmics
- Class IA: Quinidine, disopyramide, procainamide
- Class III: Sotalol, dofetilide, ibutilide, dronedarone, amiodarone, ranolazine
Antibiotics
- Macrolides: erythromycin, clarithromycin, azithromycin
- Fluoroquinolones: levofloxacin, moxifloxacin
- Trimethoprim-sulfamethoxazole, clindamycin, pentamidine
- Antimalarials: chloroquine, hydroxychloroquine
Antifungals
- Ketoconazole, itraconazole (and azoles via CYP3A4 interactions)
Antivirals
Antipsychotics
- Haloperidol, phenothiazines (thioridazine, trifluoperazine), ziprasidone, sertindole
Antidepressants
- Tricyclics and tetracyclics
Antihistamines (H1 blockers)
- Astemizole, diphenhydramine, hydroxyzine
Other drugs
- Methadone (high-dose, especially IV)
- Cocaine
- Citrate (massive blood transfusions - causes hypocalcemia)
- Loperamide (antidiarrheal, in overdose)
- Certain anesthetic agents (e.g., sevoflurane - clinical significance uncertain)
4. Cardiac Conditions
- Myocardial ischemia and infarction
- Myocarditis
- Marked bradycardia (rate-dependent QT prolongation - "pause-dependent" TdP)
- Stress cardiomyopathy (Takotsubo)
- Heart failure/cardiomyopathy
5. Endocrine Disorders
- Hypothyroidism
- Hyperparathyroidism (via hypocalcemia)
- Pheochromocytoma
- Hyperaldosteronism (via hypokalemia/hypomagnesemia)
6. Intracranial / Neurological Disorders
- Subarachnoid hemorrhage (classic - massive catecholamine surge)
- Thalamic hematoma
- Cerebrovascular accident (stroke)
- Encephalitis
- Head injury
7. Nutritional / Systemic
- Anorexia nervosa
- Starvation, liquid protein diets
- Celiac disease
- Gastroplasty / ileojejunal bypass
Key Clinical Points
- Female sex is an independent risk factor for drug-induced TdP (longer baseline QTc)
- Combination of causes is additive - e.g., a patient on sotalol who develops hypokalemia is at high risk
- First-degree relatives of congenital LQTS patients have increased sensitivity to drug-induced QT prolongation
- QTc >500 ms marks significantly elevated risk of TdP
- Acute treatment of TdP: IV magnesium sulfate 2 g + correct underlying cause + overdrive pacing if bradycardic
Sources: - Harrison's Principles of Internal Medicine 22E, p. 2013 | - Fuster and Hurst's The Heart, 15th Ed., p. 1864 | - Pfenninger and Fowler's Procedures for Primary Care, 3rd Ed.